HealthQuill
The US Food and Drug Administration has granted marketing access to Fujirebio Diagnostics, Inc.ā€™s blood test to diagnose Alzheimerā€™s disease, the first such approval in the country.
Drugs Health Pharma

Simple blood test to detect Alzheimerā€™s disease gets US regulator’s nod

HQ Team May 18, 2025: The US Food and Drug Administration has granted marketing access to Fujirebio Diagnostics, Inc.ā€™s blood test to diagnose.

Read More
Global deaths due to COVID-19 have fallen by 95% since January, and nations need to take steps to manage virus variants alongside other infectious diseases, the WHO director-general said.
Climate Health Research

Global hunger crisis reaches breaking point: 295M face starvation

HQ Team May 16, 2025: The world is losing its battle against hunger. The latestĀ Global Report on Food CrisesĀ reveals a sixth consecutive year.

Read More
South American country Peru has declared a health emergency in 20 of the nationā€™s 25 regions due to an increase in dengue cases.
Climate Health

Dengue on the rise in India: Climate change widens world danger zones

HQ Team May 16, 2025: Dengue fever has become a serious and growing health threat in India, especially between July and mid-November. Recent.

Read More
The US regulator is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the market, a move that drew ire from dental experts.
Drugs Health Pharma

US plan to remove ingestible fluoride from childrenā€™s drugs draws ire

HQ Team May 14, 2025: The US regulator is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the.

Read More
Lupin Pharma
Drugs Health Research

Role of vitamins and diets in cancer prevention, treatment

HQ Team May 15, 2025: A recent meta research by DrĀ Salvatore CortellinoĀ and ProfessorĀ Antonio Giordano, President of theĀ Sbarro Health Research OrganizationĀ (SHRO) and molecular oncologist.

Read More
The US Food and Drug Administration (FDA) has granted an accelerated approval for AbbVie Inc.ā€™s drug to treat a specific group of adult lung cancer patients who have tried other systemic treatments.
Drugs Health Pharma

AbbVieā€™s NSCLC lung cancer drug gets accelerated approval from FDA

Ā HQ Team May 15, 2025: The US Food and Drug Administration (FDA) has granted an accelerated approval for AbbVie Inc.ā€™s drug to treat.

Read More
Harvard University has amended its lawsuit against the US administration by saying that its researchers would lose another $450 million in grants from several agencies.
Health Medical Pharma

Harvard amends lawsuit as federal agencies threaten to cut short grants

HQ Team May 15, 2025: Harvard University has amended its lawsuit against the US administration by saying that its researchers would lose another.

Read More
Merck & Co. got approval from the US Food and Drug Administration for a pill to treat a rare type of tumour in adults and children aged above 12 years, according to a statement.
Drugs Health Pharma

Merckā€™s pill to treat rare type of tumour gets approval from US regulator

HQ Team May 15, 2025: Merck & Co. got approval from the US Food and Drug Administration for a pill to treat a.

Read More
Novo Nordisk and Septerna, Inc., have inked a $2.2 billion global collaboration and licensing pact to develop oral small molecules for obesity, type 2 diabetes and heart diseases.
Drugs Health Pharma

Novo Nordisk, Septerna in $2.2b deal to develop oral molecules

HQ Team May 14, 2025: Novo Nordisk and Septerna, Inc., have inked a $2.2 billion global collaboration and licensing pact to develop oral.

Read More
GSK Plc will acquire Boston Pharmaceuticalā€™s investigational lead asset, efimosfermin alfa, to treat serious liver diseases, for $2 billion in cash.
Drugs Health Pharma

GSK to buy Bostonā€™s lead drug asset for liver disease for $2 billion in cash

HQ Team May 14, 2025: GSK Plc will acquire Boston Pharmaceuticalā€™s investigational lead asset, efimosfermin alfa, to treat serious liver diseases, for $2.

Read More